| Literature DB >> 32371372 |
Zhuang Ma1, Helin Lu1, Ke Liao1, Zhilong Chen2.
Abstract
Aryl halide (Br, Cl, I) is among the most important compounds in pharmaceutical industry, material science, and agrochemistry, broadly utilized in diverse transformations. Tremendous approaches have been established to prepare this scaffold; however, many of them suffer from atom economy, harsh condition, inability to be scaled up, or cost-unfriendly reagents and catalysts. Inspired by vanadium haloperoxidases herein we presented a biomimetic approach for halogenation (Br, Cl, I) of (hetero)arene catalyzed by tungstate under mild pH in a cost-efficient and environment- and operation-friendly manner. Broad substrates, diverse functional group tolerance, and good chemo- and regioselectivities were observed, even in late-stage halogenation of complex molecules. Moreover, this approach can be scaled up to over 100 g without time-consuming and costly column purification. Several drugs and key precursors for drugs bearing aryl halides (Br, Cl, I) have been conveniently prepared based on our approach.Entities:
Keywords: Green Chemistry; Organic Chemistry; Pharmaceutical Engineering
Year: 2020 PMID: 32371372 PMCID: PMC7201191 DOI: 10.1016/j.isci.2020.101072
Source DB: PubMed Journal: iScience ISSN: 2589-0042
Figure 1Previous Approach for Halogenation (Br, Cl, I) and Our Strategy
(A) Typical examples of biologically important (hetero)aryl halides.
(B–D) (B) Previous reported approaches for halogenation developed in laboratories. (C) The reaction mechanism of vanadium haloperoxidases (V-HPO) and comparison of V-η2-peroxy and W-η2-peroxy intermediates. (D) Biomimetic halogenation catalyzed by tungstate. HMPT, hexamethylphos-phor triamide.
Condition Optimization
| Entry | Vary from Optimized Condition | Yield | Major By-products |
|---|---|---|---|
| 1 | None | 78%–83% | |
| 2 | Without HOAc | <50% conversion for 3 days | |
| 3 | Without Na2WO4-2H2O | Trace | |
| 4 | H3O40PW12-xH2O instead of Na2WO4-2H2O | 64% | |
| 5 | (NH4)10(H2W12O42)-xH2O instead of Na2WO4-2H2O | 77% | |
| 6 | LiBr instead of NaBr | 66% | |
| 7 | KBr instead of NaBr | 75% | |
| 8 | SPB instead of H2O2 | N.R | |
| 9 | MeOH instead of EtOH | 67% | |
| 10 | H2O instead of EtOH | 67% | |
| 11 | Na2WO4-2H2O, 1 mol % instead of 5 mol % | 67% | |
| 12 | 2.0 equiv H2O2 instead of 6.0 equiv | 57% | |
N.R, no reaction
All the reactions were conducted in 1.0-mmol scale (1-1) for 12 h, isolated yield.
2.0 equivalents of HOAc was utilized.
1.5 equivalents NaBr and 2.0 equiv. HOAc were utilized.
1.5 equivalents of NaBr and 2.0 equivalents of HOAc were utilized, and the reactions were conducted at 50°C
Substrate Scope of Tungstate-Catalyzed Oxidative Bromination of (Hetero)Arene
p, para-bromination product; o, ortho-bromination product; m, mono-bromination; d, dibromination product; rr, regioselective ration; brsm, based on recovered starting material.
Unless noted, all the reactions were conducted in 1.0-mmol scale (1) with Na2WO4-2H2O (5 mol %), NaBr (1.1 equivalents), H2O2 (30 % aq., 6.0 equivalents.), HOAc (1.1 equiv.) in EtOH (5.0 mL) at 30°C isolated yield (see also Figure S1).
The reactions were conducted in H2O with Na2WO4-2H2O (2.5 mol %), NaBr (1.1 equivalent), H2O2 (30 % aq., 1.1 equivalent) and HOAc (1.1 equivalent) (see also Figure S2).
5.0-mmol scale.
2.2 mmol NaBr (2.2 equivalents) and HOAc (2.2 equivalents) were utilized.
Figure 2Application in Synthesis of Selected Drugs and Key Precursors
(A) Synthesis of quinoline drugs or key precursors, including clioquinol, iodoquinado, broxyquinoline, and precursor for broxaldine.
(B) Synthesis of key precursor for brimonidine, a drug to treat ocular hypertension, rosacea, and open-angle glaucoma.
(C) Synthesis of key precursor bromopride and metoclopramide, antiemetic drugs.
(D) Synthesis for benzofuran drugs: benzbromaron, benziodarone, and amiodarone.
Substrate Scope of Tungstate-Catalyzed Oxidative Chlorination and Iodination
brsm, based on recovered starting material; p, para-chlorination product; o, ortho-chlorination product.
Unless noted, the chlorination reactions were carried out in 1.0-mmol scale (1) in MeCN (5.0 mL) at 50°C with Na2WO4-2H2O (5 mol %), H2O2 (30% aq. 4.0 equiv.), BaCl2·2H2O (1.2 equiv), and HOAc (1.0 equiv) (see also Figure S3).
Trifluoro acetic acid was used instead of HOAc.
The iodination reaction was conducted in 1.0-mmol scale (1) in EtOH at room temperature (20–25°C) with Na2WO4-2H2O (5 mol %), H2O2 (30% aq. 6.0 equiv), KI (1.1 equiv), and HOAc (1.1 equiv) (see also Figure S4).
2.2 equivalents of KI and HOAc were used.
No catalyst was added as control experiments.
100-g-Scale Bromination
Figure 3Hypothesis of Mechanism of Bromination/Iodination and Control Experiments
(A) Radical trapping experiment.
(B) Hypothesis of H-bonding effect with Brønsted acid.
(C) Control experiments to probe the importance of H-bonding.
(D) Effects of metal ion in chloride salts in chlorination.
Figure 4Proposed Reaction Mechanism